Xarelto gets no love from FDA panel
May 24 2012
Fuzzy data and missing patients led the majority of the FDA panel members to vote against allowing Bayer/J&J's drug to ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.